相关实验视频
Updated: May 9, 2025

05:17
Hybrid PET/MRI Imaging of Alzheimer's Disease Based on 18F-AV-1451
Published on: April 18, 2025
56
寻找唾液作为阿尔茨海默氏症类型痴呆症的诊断方法
Gustavo Alves Andrade Dos Santos1,2,3, Francisco de Assis Carvalho do Vale4, Valeria Paula Sassoli Fazan1
1Universidade de São Paulo, Faculdade de Medicina de Ribeirão Preto, Departamento de Anatomia e Cirurgia, Ribeirão Preto SP, Brazil.
Dementia & neuropsychologia
|April 29, 2025
概括
唾液中的酸化陶 (pTAU) 可能成为阿尔茨海默病 (AD) 的新生物标志物. 在AD患者中观察到较高的pTAU水平,这表明唾液是潜在的非侵入性诊断工具.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 生物标志物发现发现
背景情况:
- 阿尔茨海默病 (AD) 缺乏明确的生物标志物,使诊断复杂化.
- 研究正在确定与AD病理生理学,炎症和糖尿病相关的潜在生物标志物.
- 生物标志物可以在各种体液中检测到,包括血,唾液和脑脊液.
研究的目的:
- 研究蛋白作为阿尔茨海默病的唾液生物标记物的潜力.
- 为了确定唾液蛋白水平与阿尔茨海默病存在之间的相关性.
- 探索基于唾液的AD诊断的实用性.
主要方法:
- 从76名患者 (阿尔茨海默氏症和对照组) 的唾液样本中分析了陶蛋白水平.
- 在不同年龄组中比较tau蛋白度.
- 使用酸化 (pTAU) 和总作为潜在的生物标志物.
主要成果:
- 酸化陶 (pTAU) 度在阿尔茨海默病患者中显著更高.
- 与AD患者相比,在没有AD的老年人中,pTAU水平较低.
- 没有AD的年轻人表现出明显较低的pTAU水平.
- 总tau水平在所有评估组中显示出最小的变化.
结论:
- 唾液显示出作为阿尔茨海默病诊断的辅助方法的希望.
- 唾液采集的非侵入性和成本效益性质提供了显著的优势.
- 需要进一步的研究来验证唾液pTAU作为AD的可靠生物标志物.
相关概念视频
Alzheimer's Disease: Overview
315
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
315
Alzheimer's Disease: Treatment
128
Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
128
Dementia
64
Dementia is a collective term for cognitive disorders primarily affecting memory, thinking, and reasoning. It is not a specific disease but a syndrome, with Alzheimer's disease being the most common cause, accounting for approximately 60-80% of cases. Other types include vascular dementia, Lewy body dementia, and frontotemporal dementia. Dementia affects millions worldwide, particularly older adults, though it is not a normal part of aging.
The progression of dementia is generally gradual....
The progression of dementia is generally gradual....
64

